Emergency contraceptives
Movement among advocacy groups could lead to a citizen petition for OTC sale of ECs, James Trussell, PhD, Princeton University Office of Population Research, confirms at a Nov. 16 briefing sponsored by the Henry J. Kaiser Family Foundation. The National Black Women's Health Project, National Women's Health Network, National Abortion Rights Action League and Population Council have voiced support for lessening Rx restrictions on ECs (1"The Tan Sheet" July 10, p. 3). Preven marketer Gynetics and Women's Capital Corporation, which markets Plan B, have expressed interest in bringing their Rx emergency contraceptives over-the-counter, although neither has filed a switch NDA
More from Archive
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
More from Pink Sheet
It is unclear in a revised staff manual guide whether Commissioner's National Priority Voucher program approval “recommendations” from the drug and biologic center directors will be advisory or decisional, experts told the Pink Sheet.
Revised recommendation is based on most recent data on circulating strains in US, where KP.3 is now dominant. Novavax sticks with plans targeting the JN.1 ‘parent strain.’
Pink Sheet reporter and editors discuss the US FDA’s changes to the COVID-19 vaccine indication and its revocation of the vaccine emergency use authorizations, as well as new vaccine coverage and reimbursement questions.




